Business

TabaFund Commits $8,000,000 Investment in DATATRAK International, Inc. (OTC: DTRK) Increasing Its Long-Term Investment in the Clinical Trials Software-as-a-Service Enterprise Platform

TabaFund Commits $8,000,000 Investment in DATATRAK International, Inc. (OTC: DTRK) Increasing Its Long-Term Investment in the Clinical Trials Software-as-a-Service Enterprise Platform.

articleDatatrak International, Inc.August 15, 20185/company/datatrak-international-inc/news/tabafund-commits-dollar8000000-investment-in-datatrak-international-inc-otc-dtrk-increasing-its-long-term-investment-in-the-clinical-trials-software-as-a-service-enterprise-platform
TabaFund Commits $8,000,000 Investment in DATATRAK International, Inc. (OTC: DTRK) Increasing Its Long-Term Investment in the Clinical Trials Software-as-a-Service Enterprise Platform

About this update from Datatrak International, Inc.

[{"type":"text","content":"\n\n\n\nTabaFund Commits $8,000,000 Investment in DATATRAK International, Inc. (OTC: DTRK) Increasing Its Long-Term Investment in the Clinical Trials Software-as-a-Service Enterprise Platform\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTabaFund Commits $8,000,000 Investment in DATATRAK International, Inc. (OTC: DTRK) Increasing Its Long-Term Investment in the Clinical Trials Software-as-a-Service Enterprise Platform\nPR Newswire\nCLEVELAND, Aug. 15, 2018\n\n\n\nCLEVELAND, Aug. 15, 2018 /PRNewswire/ -- DATATRAK International, Inc. (OTC Markets: DTRK), a Vertical SaaS (software-as-a-service) provider and innovation leader of cloud-based technologies for the life sciences industry, announces an $8,000,000 additional commitment from its long-term investor TabaFund (Tabatabai Investment Partners LP) to expand the company's growth in sales and new technologies for the life sciences and clinical research industry. \n\n\"Datatrak has a strong management team that we continue to believe in and this investment further encourages their pursuit of the vision our CEO, Jim Bob Ward, has set forth and continues to execute upon,\" said Alex Tabatabai, chief investment officer of TabaFund. \"TabaFund continues to demonstrate significant confidence by making an even larger, long-term investment in our company,\" said Jim Bob Ward, President and CEO of DATATRAK. \"TabaFund led the proxy campaign to change past leadership in 2015, then in 2016, TabaFund invested an additional $1,500,000 in the company to reach our current profitability. Now, TabaFund is doubling down to fuel our growth and platform expansion plans.\" \n\n\"TabaFund had a choice of investing its money into any of the eClinical companies, and the decision to invest our money into DATATRAK is obvious when you review the competitive landscape and their respective technology. DATATRAK is the only eClinical company with a vertically integrated SaaS enterprise caliber platform built on a single unified source code, so the Company can put the money we invest into innovation, deeper vertical integration and business intelli...

More updates from Datatrak International, Inc.